Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Schuster

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
The Lancet. Oncology|December 7, 2018
CD19-directed CAR T cells gain tractionStephen J Schuster
Hematological Oncology|June 9, 2021
Bispecific antibodies for the treatment of lymphomas: Promises and challengesStephen J Schuster
The New England Journal of Medicine|April 18, 2019
Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. ReplyStephen J Schuster,
NEJM Evidence|February 6, 2024
ROR1 for Lymphoid CancersStephen J Schuster
Blood|October 1, 2020
NextGen CARs: the race is onStephen J Schuster
PET Clinics|May 10, 2016
The Evolving Role of Medical Imaging in Lymphoma Management: The Clinician's PerspectiveJakub Svoboda, Stephen J Schuster
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?Tahamtan Ahmadi, Stephen J Schuster
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure?Joanna M Rhodes, Stephen J Schuster
Mayo Clinic Proceedings|April 14, 2006
Clinical remission of acquired thrombasthenia with low-dose methotrexate in a patient with systemic lupus erythematosusNelson S Yee, Stephen J Schuster
PET Clinics|May 10, 2016
PET Imaging of LymphomaRebecca L Elstrom, Stephen J Schuster
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
The Lancet. Oncology|December 7, 2018
CD19-directed CAR T cells gain tractionStephen J Schuster
Hematological Oncology|June 9, 2021
Bispecific antibodies for the treatment of lymphomas: Promises and challengesStephen J Schuster
The New England Journal of Medicine|April 18, 2019
Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. ReplyStephen J Schuster,
NEJM Evidence|February 6, 2024
ROR1 for Lymphoid CancersStephen J Schuster
Blood|October 1, 2020
NextGen CARs: the race is onStephen J Schuster
PET Clinics|May 10, 2016
The Evolving Role of Medical Imaging in Lymphoma Management: The Clinician's PerspectiveJakub Svoboda, Stephen J Schuster
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?Tahamtan Ahmadi, Stephen J Schuster
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure?Joanna M Rhodes, Stephen J Schuster
Mayo Clinic Proceedings|April 14, 2006
Clinical remission of acquired thrombasthenia with low-dose methotrexate in a patient with systemic lupus erythematosusNelson S Yee, Stephen J Schuster
PET Clinics|May 10, 2016
PET Imaging of LymphomaRebecca L Elstrom, Stephen J Schuster
Pageof 26